Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Gelteq Ltd Logo
Develops and manufactures a gel-based oral delivery system for drugs and nutrients.
United States of America
GELS
GemVax & KAEL Co.,Ltd. Logo
Clinical-stage biopharma developing therapeutics for neurodegenerative diseases.
South Korea
082270
Gencurix Inc. Logo
Develops and commercializes diagnostic solutions for precision medicine in oncology.
South Korea
229000
GENEDRIVE PLC Logo
Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.
United Kingdom
GDR
GENELUX Corp Logo
Clinical-stage biopharma developing oncolytic viral immunotherapies for solid tumors.
United States of America
GNLX
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostic products for infectious diseases.
South Korea
109820
Generation Bio Co. Logo
Develops siRNA therapeutics delivered via ctLNPs for T cell-driven autoimmune diseases.
United States of America
GBIO
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
South Korea
095700
Genfit S.A. Logo
Biopharmaceutical firm developing therapies and diagnostics for liver diseases.
United States of America
GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Specialty pharmaceutical firm for rare diseases and unmet medical needs.
Türkiye
GENIL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.